Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

The Medicines Company Company Profile (NASDAQ:MDCO)

Consensus Ratings for The Medicines Company (NASDAQ:MDCO) (?)
Ratings Breakdown: 5 Hold Rating(s), 2 Buy Rating(s)
Consensus Rating:Hold (Score: 2.29)
Consensus Price Target: $30.00 (7.07% upside)

Analysts' Ratings History for The Medicines Company (NASDAQ:MDCO)
Show:
DateFirmActionRatingPrice TargetDetailsShare
3/27/2015Citigroup Inc.Initiated CoverageNeutral$30.00ViewTweet This Rating  Share This Rating on StockTwits
3/19/2015MizuhoInitiated CoverageNeutral$30.00ViewTweet This Rating  Share This Rating on StockTwits
2/20/2015ZacksReiterated RatingNeutral -> Neutral$30.00ViewTweet This Rating  Share This Rating on StockTwits
1/26/2015Citigroup Inc.Boost Price TargetNeutral$27.00 -> $30.00ViewTweet This Rating  Share This Rating on StockTwits
1/21/2015Leerink SwannUpgradeMarket Perform -> Outperform$24.00 -> $31.00ViewTweet This Rating  Share This Rating on StockTwits
11/20/2014ZacksReiterated RatingNeutral -> Neutral$26.00ViewTweet This Rating  Share This Rating on StockTwits
11/20/2014Credit Suisse Group AGUpgradeNeutral -> Outperform$27.00 -> $33.00ViewTweet This Rating  Share This Rating on StockTwits
10/28/2014Credit Suisse Group AGReiterated RatingNeutral$24.00 -> $27.00ViewTweet This Rating  Share This Rating on StockTwits
10/23/2014Citigroup Inc.Reiterated RatingNeutral$30.00 -> $27.00ViewTweet This Rating  Share This Rating on StockTwits
10/23/2014Bank of AmericaLower Price TargetBuy -> Neutral$37.00 -> $27.00ViewTweet This Rating  Share This Rating on StockTwits
10/10/2014Credit Suisse Group AGReiterated RatingNeutral$28.00 -> $26.00ViewTweet This Rating  Share This Rating on StockTwits
8/21/2014ZacksReiterated RatingNeutral -> Neutral$28.00ViewTweet This Rating  Share This Rating on StockTwits
4/17/2014Leerink SwannDowngradeOutperform -> Market Perform$30.00 -> $27.00ViewTweet This Rating  Share This Rating on StockTwits
4/2/2014Piper JaffrayDowngradeOverweight -> Neutral$41.00 -> $29.00ViewTweet This Rating  Share This Rating on StockTwits
3/31/2014TheStreetDowngradeBuy -> HoldViewTweet This Rating  Share This Rating on StockTwits
2/13/2014RBC CapitalLower Price TargetOutperform$50.00 -> $44.00ViewTweet This Rating  Share This Rating on StockTwits
2/13/2014Credit Suisse Group AGDowngradeOutperform -> Neutral$45.00 -> $35.00ViewTweet This Rating  Share This Rating on StockTwits
2/13/2014Jefferies GroupDowngradeBuy -> Hold$38.50 -> $27.00ViewTweet This Rating  Share This Rating on StockTwits
12/5/2013RBC CapitalBoost Price TargetOutperform$41.00 -> $50.00ViewTweet This Rating  Share This Rating on StockTwits
10/10/2013Leerink SwannReiterated RatingOutperform$40.00 -> $42.00ViewTweet This Rating  Share This Rating on StockTwits
8/15/2013Bank of AmericaUpgradeNeutral -> Buy$36.00 -> $40.00ViewTweet This Rating  Share This Rating on StockTwits
8/6/2013RBC CapitalBoost Price TargetOutperform$41.00 -> $42.00ViewTweet This Rating  Share This Rating on StockTwits
7/16/2013Credit Suisse Group AGLower Price TargetOutperform$38.00 -> $37.00ViewTweet This Rating  Share This Rating on StockTwits
7/12/2013RBC CapitalReiterated RatingOutperform$41.00ViewTweet This Rating  Share This Rating on StockTwits
6/20/2013OppenheimerInitiated CoverageOutperform -> Market PerformViewTweet This Rating  Share This Rating on StockTwits
6/5/2013Piper JaffrayInitiated CoverageOverweightViewTweet This Rating  Share This Rating on StockTwits
4/25/2013Jefferies GroupBoost Price TargetBuy$36.00 -> $38.50ViewTweet This Rating  Share This Rating on StockTwits
(Data available from 4/1/2013 forward)